Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1261473 (
sarcoma
)
25,952
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
gag
-onc fusion proteins of three isolates of feline sarcoma virus (ST-FeSV, GA-FeSV, TP1-FeSV) from a stable noncovalent complex with two cellular phosphoproteins, pp90 and pp50. These two phosphoproteins are the same phosphoproteins which have been shown to complex with the transforming proteins of Rous sarcoma virus, Fujinami
sarcoma
virus, Yamaguchi 73 virus (Lipsich et al., 1982), and PRCII avian sarcoma virus (Adkins et al., 1982). Both the monomeric and complex-associated
gag
-onc fusion proteins are phosphorylated on serine, threonine, and tyrosine; however, quantitative and/or qualitative differences in phosphorylation of the two species were apparent. Only the monomeric form of the
gag
-onc proteins was able to undergo tyrosine specific autophosphorylation in an in vitro kinase reaction. Both the monomeric and complex-associated forms of the proteins were acylated, the complex-associated molecules to a greater degree. Pulse-chase experiments indicated that newly synthesized
gag
-onc molecules become rapidly incorporated into the complex and that a significant amount of these molecules remained associated with the complex for more than 20 hr.
...
PMID:Characterization of the monomeric and complex-associated forms of the gag-onc fusion proteins of three isolates of feline sarcoma virus: phosphorylation, kinase activity, acylation, and kinetics of complex formation. 242 12
Antibodies present in two peritoneal exudates of rats bearing abdominal tumors induced by UR2-transformed rat cells were characterized. The ability to immunoprecipitate p68gag-ros and to inhibit the protein and phospholipid kinase activities of this protein was investigated. One of the exudates specifically inhibited tyrosyl phosphorylation by p68gag-ros but not the activity of other known tyrosyl kinases, such as p150gag-fps of UR1 avian sarcoma virus, p60src, and the insulin receptor. It precipitated p68gag-ros but not Pr76 or other
gag
-related proteins from UR2-infected cells. Phosphorylation of phosphatidylinositol was not affected by this exudate, suggesting that this activity is not intrinsic to p68gag-ros. Another exudate precipitated p68gag-ros but not
gag
-related proteins from UR2-infected cells or p140gag-fps from Fujinami
sarcoma
virus-infected cells. These results demonstrated that the antibodies in these exudates recognized epitopes present in the ros portion of the fused protein p68gag-ros, but only one of the two exudates inhibited the intrinsic tyrosyl kinase of p68gag-ros.
...
PMID:Specific inhibition of tyrosine kinase activity by an antibody to the v-ros oncogene product. 243 Jan 10
We have found human DNA to contain a number of sequences related to simian
sarcoma
associated virus (SSAV). One of these sequences was isolated from a human genomic library. The molecular clone, termed S71, contains regions homologous to SSAV
gag
and pol fragments and SSAV LTR. Furthermore, hybridization experiments and DNA sequencing revealed distinct homologies to the reverse transcriptase coding region of several other retroviruses including baboon endogenous virus (BaEV) and murine leukemia viruses (MuLV) as well as retrovirus-like elements. Some sequence homology was also found with the C-type retrovirus-related multicopy human clone 4-1. S71 is present in only one copy per human genome equivalent and exhibits an EcoRI restriction fragment length polymorphism.
...
PMID:Isolation of an SSAV-related endogenous sequence from human DNA. 243 42
To investigate the mechanism of cell transformation by the retroviral v-sis gene, we examined the mode of its mRNA expression after infection of primate fibroblasts with Simian
Sarcoma
Virus (SSV/SSAV). Surprisingly transient expression of the 5.3 kb transcript of v-sis was detected between day two and four after infection. Addition of cycloheximide did not reverse the down-regulation of v-sis expression. Suramin, which uncouples the PDGF receptor complex, had no effect on the pattern of v-sis expression. A marginal but non-transient expression of c-myc and c-fos mRNA upon v-sis expression was detected. Studies on nuclear run-off and m-RNA stability suggest that the half-life time of v-sis mRNA is about 8 h or longer and that its expression is controlled rather by transcriptional than by post-transcriptional mechanisms. The up and down regulation of v-sis expression is independent of the expression of the helper virus (SSAV)
gag
-genes. This indicates that v-sis oncogene (SSV) and structural genes of the helper virus (SSAV) are obviously under separate expression control.
...
PMID:V-sis gene (SSV) is expressed transiently and independently of v-gag (SSAV) after infection of fibroblasts with SSV/SSAV. 255 Aug 73
src, abl, and fps/fes are prototypes for a family of genes encoding nonreceptor protein-tyrosine kinases. The oncogenic potential of the v-fps protein-tyrosine kinase was investigated by introduction of the
gag
-fps coding sequence of Fujinami
sarcoma
virus into the mouse germ line. Transgenic mice with v-fps under the transcriptional control of a 5' human beta-globin promoter (GF) or with both 5' and 3' beta-globin regulatory sequences (GEF) were viable. Unexpectedly, both GF and GEF transgenes were expressed in a wide variety of tissues and induced a spectrum of benign and malignant tumors. These tumors, which included lymphomas, thymomas, fibrosarcomas, angiosarcomas, hemangiomas, and neurofibrosarcomas, developed with various frequencies after latent periods of 2 to 12 months. The majority of lymphoid neoplasms appeared to be of T-cell origin and were monoclonal, as judged by rearrangements of the T-cell receptor beta or immunoglobulin genes. Some tissues that expressed the v-fps oncogene, such as heart, brain, lung, and testes, developed no malignant tumors. The v-fps protein-tyrosine kinase therefore has a broad but not unrestricted range of oncogenic activity in cells of lymphoid and mesenchymal origin. The incomplete penetrance of the neoplastic phenotype and the monoclonality of lymphoid tumors suggest that tumor formation in v-fps mice requires genetic or epigenetic events in addition to expression of the P130gag-fps protein-tyrosine kinase.
...
PMID:Lymphoid and mesenchymal tumors in transgenic mice expressing the v-fps protein-tyrosine kinase. 255 99
Friend Leukemia Virus (FLV) particles contain a protease which cleaves not only its own
gag
precursor but also the
gag
polyprotein of simian
sarcoma
virus (SSV). To determine the localization of the enzyme within the virion, purified virus was fractionated. According to our studies most of the proteolytic activity is located within the retroviral core. Since ionic detergents inhibit the protease, heat treatment was found to be the most effective way to release the molecule from the virus particle. The in vitro studies indicate a high resistance of the enzyme to different kinds of heat treatment.
...
PMID:Properties of retroviral protease responsible for gag precursor cleavage. 267 63
The development and isotype distribution of Moloney murine leukemia virus (M-MuLV)-specific serum antibodies following primary inoculation with Moloney murine
sarcoma
/leukemia virus (M-MuSV/M-MuLV) in adult BALB/c mice have been investigated using an enzyme-linked immunosorbent assay (ELISA). The primary antibody responses to M-MuSV/M-MuLV consisted of the IgM, IgG2a, IgG2b, and IgG3 isotypes; no M-MuLV-specific serum IgG1 or IgA antibodies were detected. The detectable antibody response was biphasic, with an early peak of virus-specific titers seen between 10 and 15 days after inoculation and a second peak seen in regressor sera. Pooled regressor sera contained IgM, IgG2a, and IgG2b antibodies which bound to M-MuLV-expressing lymphoma cells. Immunoelectron microscopy with regressor sera showed IgG bound both to infected cell surfaces and to mature viral particles, while IgM bound only to infected cell surfaces. These findings were supported by immunoprecipitation analyses which demonstrated binding of the M-MuLV-specific antibodies to both virion-associated and cell-associated antigens encoded by the
gag
and env genes.
...
PMID:Isotype distribution and specificity of the antibody response to primary Moloney murine sarcoma virus infection in BALB/c mice. 267 79
Gibbon ape leukemia virus (GaLV) is a highly oncogenic C-type retrovirus capable of inducing myeloid leukemia in juvenile gibbons. GaLV is antigenically most closely related to a new world monkey virus, simian
sarcoma
associated virus (SSAV), and less to the murine and feline C-type leukemia viruses. To begin to understand how this virus induces leukemia at the molecular level, we have sequenced a GaLV genome and shown that it has a "minimal" genetic complement of 5'R-U5-
gag
-pol-env-U3-R3'. No additional genes could be identified. Such a genetic structure is identical to those of the murine and feline C-type leukemogenic viruses. Despite its suggested murine origin, the GaLV sequence is as closely related to the murine viruses as it is to the feline retroviruses. Finally the GaLV sequence is indistinguishable from that of the fragments of SSAV available indicating that, in fact, SSAV is of gibbon origin.
...
PMID:Genetic organization of gibbon ape leukemia virus. 268 60
DNA-protein interactions involving enhancer and promoter sequences within the U3 regions of several avian retroviral long terminal repeats (LTRs) were studied by DNase I footprinting. The rat CCAAT/enhancer-binding protein, C/EBP, bound to all four viral LTRs examined. The Rous sarcoma virus binding site corresponded closely to the 5' limit of the LTR enhancer; nucleotides -225 to -188 were protected as a pair of adjacent binding domains. The Fujinami
sarcoma
virus LTR bound C/EBP at a single site at nucleotides -213 to -195. C/EBP also bound to the promoter region of the enhancerless Rous-associated virus-0 LTR at nucleotides -77 to -57. The avian myeloblastosis virus LTR bound C/EBP at three sites: nucleotides -262 to -246, -154 to -134, and -55 to -39. We have previously observed binding of C/EBP to an enhancer in the
gag
gene of avian retroviruses. A heat-treated nuclear extract from chicken liver bound to all of the same retroviral sequences as did C/EBP. Alignment of the avian retroviral binding sequences with the published binding sites for C/EBP in two CCAAT boxes and in the simian virus 40, polyoma, and murine
sarcoma
virus enhancers suggested TTGNNGCTAATG as a consensus sequence for binding of C/EBP. When two bases of this consensus sequence were altered by site-specific mutagenesis of the Rous sarcoma virus LTR, binding of the heat-stable chicken protein was eliminated.
...
PMID:Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein. 272 92
The P130gag-fps protein-tyrosine kinase of Fujinami
sarcoma
virus contains an N-terminal fps-specific domain (Nfps) that is important for oncogenicity. The N-terminal 14 amino acids of p60v-src, which direct myristylation and membrane association, can replace the
gag
-Nfps sequences of P130gag-fps (residues 1 to 635), producing a highly transforming src-fps polypeptide. Conversely,
gag
-Nfps can restore modest transforming activity to a nonmyristylated v-src polypeptide. These results emphasize the modular construction of protein-tyrosine kinases and indicate that Nfps, possibly in conjunction with
gag
, functions in the subcellular localization of P130gag-fps.
...
PMID:The myristylation signal of p60v-src functionally complements the N-terminal fps-specific region of P130gag-fps. 274 47
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>